RTID-01. ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA

Arrillaga-Romany, I., Lassman, A., McGovern, S., Mueller, S., Nabors, L. B., van den Bent, M., Vogelbaum, M., Allen, J. E., Melemed, A., Tarapore, R., Yang, D., Wen, P. Y., & Cloughesy, T. (2022). RTID-01. ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA. Neuro-Oncology, 24(Supplement_7), vii249–vii249. https://doi.org/10.1093/neuonc/noac209.961
Authors:
Isabel Arrillaga‐Romany
Andrew B. Lassman
Susan L. McGovern
Sabine Mueller
Burt Nabors
Martin J. van den Bent
Michael A. Vogelbaum
Joshua E. Allen
Allen S. Melemed
Rohinton S. Tarapore
Dewen Yang
Patrick Y. Wen
Timothy F. Cloughesy
Affiliated Authors:
Andrew B. Lassman
Subjects:
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac209.961
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: